Bonesupport Ab (publ)(FRA) 2B4

Market Cap€1.40B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€22.76

+5.47%

+1.18Today

Bonesupport Ab (publ) Financials at a Glance

Market Cap

€1.40B

Revenue (TTM)

SEK 1.28B

Net Income (TTM)

SEK 213.50M

EPS (TTM)

€0.29

P/E Ratio

71.54

Dividend

€0.00

Beta (Volatility)

-0.05 (Low)

Dividend

€0.00

Beta (Volatility)

-0.05 (Low)

Price

€22.76

Volume

175

Open

€22.36

Price

€22.76

Volume

175

Open

€22.36

Previous Close

€22.76

Daily Range

€22.36 - €22.76

52-Week Range

€15.50 - €25.84

Estimated Earnings Date

Oct 22, 2026

Dividend

€0.00

Beta (Volatility)

-0.05 (Low)

Price

€22.76

Volume

175

Open

€22.36

Previous Close

€22.76

Daily Range

€22.36 - €22.76

52-Week Range

€15.50 - €25.84

Estimated Earnings Date

Oct 22, 2026

2B4 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bonesupport Ab (publ)

Bonesupport Holding AB (publ) is a specialized orthobiologics firm focused on the development and global commercialization of injectable bioceramic bone graft substitutes. The company aims to effectively treat bone voids with innovative solutions distributed across Europe, North America, and other international markets.

Products and Services

CERAMENT Bone Void Filler, a synthetic injectable material
CERAMENT G, a ceramic bone graft substitute infused with gentamicin
CERAMENT V, a synthetic bone void filler containing vancomycin

Growth Outlook

Revenue increased to SEK 355.7 million in Q2 2026, up from SEK 324 million in Q1 2026
Gross profit margin remains strong at 90.8% in Q2 2026
Active preclinical research aims to expand product offerings in bone regeneration

Financial Highlights

Net income of SEK 81.9 million reported in Q2 2026
Operating income margin of 25.2% in Q2 2026
Current ratio of 5.44 indicates strong liquidity position

Bonesupport Holding AB (publ) is positioned in the healthcare sector, specifically within medical instruments and supplies. The company has demonstrated robust financial performance, with a notable increase in revenue and net income in the most recent quarter. The strong gross profit margin reflects effective cost management and product demand. With a solid liquidity position, indicated by a current ratio of 5.44, the company is well-equipped to support ongoing research and development initiatives. The focus on innovative solutions for bone regeneration presents significant growth opportunities, making Bonesupport an intriguing option for potential investors interested in the healthcare sector.

AI Generated • Oct 13, 2026

Industry

Biotechnology

Sector

Health Care

Employees

139

CEO

Torbjörn Sköld, MBA

Website

www.bonesupport.com

Headquarters

Lund, SN 223 70, SE

2B4 Financials

Key Financial Metrics (TTM)

Gross Margin

92.05%

Operating Margin

24.28%

Net Income Margin

16.63%

Return on Equity

23.82%

Return on Capital

31.68%

Return on Assets

19.10%

Earnings Yield

1.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

€1.40B

Shares Outstanding

65.49M

Volume

175

Avg. Volume

269.424

Financials (TTM)

Gross Profit

SEK 1.18B

Operating Income

SEK 311.50M

EBITDA

SEK 315.60M

Operating Cash Flow

SEK 276.47M

Capital Expenditure

-SEK 4.30M

Free Cash Flow

SEK 272.17M

Cash & ST Invst.

SEK 434.31M

Total Debt

SEK 17.74M

Bonesupport Ab (publ) Performance Analysis

Bonesupport Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	SEK 30,916,302	47.4%
2023	2023-12-31	SEK 51,500,721	66.6%
2024	2024-12-31	SEK 78,584,608	52.6%
2025	2025-12-31	SEK 106,126,118	35.0%

Bonesupport Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	2.6%
Q4	2025-12-31	6.8%
Q1	2026-03-31	4.0%
Q2	2026-06-30	9.8%

Bonesupport Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	SEK -0.10	-24.5%
2023	2023-12-31	SEK 0.33	N/A
2024	2024-12-31	SEK 0.18	-46.1%
2025	2025-12-31	SEK 0.19	9.5%

Bonesupport Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-35.4%
Q4	2025-12-31	29.4%
Q1	2026-03-31	21.2%
Q2	2026-06-30	53.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

SEK 355.72M

+25.1%

Gross Profit

SEK 323.02M

+23.0%

Gross Margin

90.81%

N/A

Market Cap

€1.40B

N/A

Market Cap/Employee

€9.98M

N/A

Employees

140

N/A

Net Income

SEK 81.88M

+54.3%

EBITDA

SEK 91.70M

+61.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

SEK 434.31M

+40.2%

Total Debt

SEK 17.74M

+33.3%

Accounts Receivable

SEK 221.71M

+16.4%

Inventory

SEK 167.56M

+26.6%

Long Term Debt

SEK 2.47M

-56.5%

Short Term Debt

SEK 15.27M

+100.0%

Return on Assets

19.10%

N/A

Return on Invested Capital

32.76%

N/A

Free Cash Flow

SEK 64.60M

+35.0%

Operating Cash Flow

SEK 67.09M

+34.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,709.28-0.01%

^DJIDJI

^DJIDJI$51,466.30-0.00%

^IXICNASDAQ

^IXICNASDAQ$26,684.28-0.02%

BTCBitcoin

BTCBitcoin$81,564.00-0.02%

SPCXSPCX

SPCXSPCX$152.06-0.03%

AAPLAAPL

AAPLAAPL$342.68+0.00%

AMZNAMZN

AMZNAMZN$253.61-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

BACBank of America

BACBank of America$51.39-4.76%

NVDANvidia

NVDANvidia$221.30-3.16%

CRWVCoreWeave

CRWVCoreWeave$65.78-15.46%

INTCIntel

INTCIntel$98.12-4.56%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$110.54-13.35%

CIFRCipher Digital

CIFRCipher Digital$9.94-12.35%

SKYDSkydance

SKYDSkydance$7.06-23.84%

Questions About 2B4

What is the current price of Bonesupport Ab (publ)?

Bonesupport Ab (publ) is trading at €22.76 per share.

What is the 52-week range for Bonesupport Ab (publ)?

Over the past 52 weeks, Bonesupport Ab (publ) has traded between €15.50 and €25.84.

How much debt does Bonesupport Ab (publ) have?

As of the most recent reporting period, Bonesupport Ab (publ) reported total debt of SEK 915.59K.

How much cash does Bonesupport Ab (publ) have on hand?

Bonesupport Ab (publ) reported SEK 39.25M in cash and cash equivalents in its most recent financial results.

What is Bonesupport Ab (publ)’s dividend yield?

Bonesupport Ab (publ) does not currently have a dividend yield.

Bonesupport Ab (publ)(FRA) 2B4

Bonesupport Ab (publ) Financials at a Glance

2B4 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bonesupport Ab (publ)

2B4 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bonesupport Ab (publ) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 2B4

What is the current price of Bonesupport Ab (publ)?

What is the 52-week range for Bonesupport Ab (publ)?

How much debt does Bonesupport Ab (publ) have?

How much cash does Bonesupport Ab (publ) have on hand?

What is Bonesupport Ab (publ)’s dividend yield?

Premium Investing Services